https://pubmed.ncbi.nlm.nih.gov/31406485/
The recent advent of immunomodulatory therapies into the clinic has demanded the identification of innovative predictive biomarkers to identify patients most...
the clinictumormutationburdencomprehensive
https://www.prnewswire.com/news-releases/seracare-life-sciences-launches-first-ever-tumor-mutational-burden-reference-materials-300949277.html
/PRNewswire/ -- SeraCare Life Sciences, part of the LGC Clinical Diagnostics Business Unit and a manufacturer and leading partner to global in vitro...
tumor mutational burdenlife sciencesfirst everlaunchesreference